Atogepant

157 interactions 1 explained in plain English 45 cited references
Also sold as: Qulipta Qulipta®
About Atogepant

Atogepant is a calcitonin gene-related peptide receptor antagonist used to help prevent migraine headaches. Read the full Atogepant drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 12, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ensitrelvir Nafcillin Injection Voxilaprevir Voriconazole Voclosporin Vinblastine
1 Contraindicated 152 Major 4 Moderate
All (157) Contraindicated (1) Major (152) Moderate (4)

Contraindicated

Atogepant Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.